- Home
- GOOG vs ABBV Comparison
GOOG vs ABBV Comparison
Compare GOOG & ABBV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GOOG | ABBV |
|---|---|---|
| Founded | 1998 | 2012 |
| Country | United States | United States |
| Employees | 190820 | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.6T | 358.5B |
| IPO Year | N/A | 2012 |
Fundamental Metrics
Financial Performance| Metric | GOOG | ABBV |
|---|---|---|
| Price | $344.00 | $235.23 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 44 | 18 |
| Target Price | ★ $357.61 | $253.71 |
| AVG Volume (30 Days) | ★ 18.8M | 3.9M |
| Earning Date | 04-29-2026 | 04-29-2026 |
| Dividend Yield | 0.24% | ★ 3.39% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | ★ $61,160,000,000.00 |
| Revenue This Year | $20.79 | $11.87 |
| Revenue Next Year | $15.27 | $8.12 |
| P/E Ratio | ★ $28.14 | $601.87 |
| Revenue Growth | N/A | ★ 8.57 |
| 52 Week Low | $170.86 | $181.75 |
| 52 Week High | $404.47 | $244.81 |
Technical Indicators
Market Signals| Indicator | GOOG | ABBV |
|---|---|---|
| Relative Strength Index (RSI) | 37.40 | 66.38 |
| Support Level | $343.63 | $220.11 |
| Resistance Level | $345.68 | $237.81 |
| Average True Range (ATR) | 11.14 | 5.28 |
| MACD | -2.64 | 0.87 |
| Stochastic Oscillator | 12.94 | 92.72 |
Price Performance
Historical ComparisonAbout GOOG Alphabet Inc.
Alphabet is a holding company that wholly owns internet giant Google. The California-based company derives slightly less than 90% of its revenue from Google services, the vast majority of which is advertising sales. Alongside online ads, Google services houses sales stemming from Google's subscription services (YouTube TV and YouTube Music, among others), platforms (sales and in-app purchases on Play Store), and devices (Chromebooks, Pixel smartphones, and smart home products such as Chromecast). Google's cloud computing platform accounts for roughly 10% of Alphabet's revenue. The firm's investments in up-and-coming technologies such as self-driving cars (Waymo), health (Verily), and internet access (Google Fiber) make up the rest.
About ABBV AbbVie Inc.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.